Clinical Trials Directory

Trials / Completed

CompletedNCT06903598

Scalp Blocks for Pediatric External Ventricular Drainage Placement

Anesthesia and Analgesia Methods in Pediatric External Ventricular Drainage Placement

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
Hande Gurbuz · Other Government
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Not accepted

Summary

External ventricular drainage (EVD) provides cerebrospinal fluid drainage in hydrocephalus. In adults, the neurosurgeon can place EVD at the bedside. In children, it is mainly preferred to be placed in the operating room under general anesthesia. However, general anesthesia may negatively affect oxygenation (during the intubation period) or cerebral blood flow (due to hypotension). This study investigates the use of regional block methods (without general anesthesia) in children for EVD placement.

Detailed description

External ventricular drainage (EVD) provides cerebrospinal fluid drainage in hydrocephalus. In adults, EVD can be placed by the neurosurgeon at the bedside. In children, it is mainly preferred to be placed in the operating room under general anesthesia. However, general anesthesia may negatively affect oxygenation during a prolonged intubation period, leading to hypoxemia. Furthermore, hypotensive effects of general anesthesia may cause ischemia due to decreased cerebral blood flow. Additionally, on the other hand, painful stimuli caused by surgical incisions or pins may cause hemorrhagic events due to a hypertensive period. Therefore, scalp blocks and local anesthetic infiltrations are recommended to prevent such adverse events. Although general anesthesia has been a routine for many anesthesiologists for EVD placement in children, this research hypothesizes that scalp blocks (along with sedatives) can be used as an anesthesia method for EVD placement. This study investigates the use of regional block methods (to avoid general anesthesia) in children for EVD placement.

Conditions

Timeline

Start date
2021-08-25
Primary completion
2022-08-28
Completion
2022-09-01
First posted
2025-03-31
Last updated
2025-03-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06903598. Inclusion in this directory is not an endorsement.